[(1,2,5,6-η)-1,5-Cyclooctadiene][(4S)-2-[(5R)-6-(diphenylphosphino-κP)spiro[4.4]nona-1,6-dien-1-yl]-4,5-dihydro-4-(phenylmethyl)oxazole-κN3]-()Iridium(I) Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate
98%
science Other reagents with same CAS 1195511-56-8
blur_circular Chemical Specifications
description Product Description
This complex is primarily used in asymmetric catalysis, particularly in hydrogenation reactions. It is highly effective in producing enantiomerically pure compounds, which are crucial in the pharmaceutical industry for the synthesis of chiral drugs. The compound's unique structure allows it to selectively catalyze the addition of hydrogen to specific substrates, ensuring high enantioselectivity and yield. Additionally, it is employed in the fine chemicals sector for the production of specialty chemicals and intermediates. Its stability and efficiency make it a valuable tool in organic synthesis, especially in processes requiring precise control over stereochemistry.
shopping_cart Available Sizes & Pricing
Cart
No products